314 related articles for article (PubMed ID: 19237695)
1. Statins: not just for the young or the faint of heart.
Coull BM; Johnston SC
Neurology; 2009 Feb; 72(8):684-5. PubMed ID: 19237695
[No Abstract] [Full Text] [Related]
2. [Coronary heart disease patient reaches LDL level of 100 mg/dl with atorvastatin: how do you continue treatment next year?].
Weizel A; Sawicki PT
MMW Fortschr Med; 2004 Dec; 146(51-52):14, 16. PubMed ID: 15675236
[No Abstract] [Full Text] [Related]
3. Potential neurological value of statins increases.
Bonetta L
Nat Med; 2002 Jun; 8(6):541. PubMed ID: 12042786
[No Abstract] [Full Text] [Related]
4. Statins for high-risk patients without heart disease or high cholesterol.
Med Lett Drugs Ther; 2006 Jan; 48(1225):1-3. PubMed ID: 16374400
[No Abstract] [Full Text] [Related]
5. What price atorvastatin?
Drug Ther Bull; 2012 Jul; 50(7):73. PubMed ID: 22764068
[No Abstract] [Full Text] [Related]
6. Atorvastatin: a new agent for hyperlipidemia.
Kupecz D
Nurse Pract; 1997 Nov; 22(11):87-8, 90, 93. PubMed ID: 9403876
[No Abstract] [Full Text] [Related]
7. [Decreasing LDL level moderately or drastically. Is differential therapy with statins available? (interview by Dirk Einecke)].
März W
MMW Fortschr Med; 2004 Jul; 146(27-28):53. PubMed ID: 15526673
[No Abstract] [Full Text] [Related]
8. Effect of atorvastatin in elderly patients with a recent stroke or transient ischemic attack.
Chaturvedi S; Zivin J; Breazna A; Amarenco P; Callahan A; Goldstein LB; Hennerici M; Sillesen H; Rudolph A; Welch MA;
Neurology; 2009 Feb; 72(8):688-94. PubMed ID: 18768917
[TBL] [Abstract][Full Text] [Related]
9. [To lessen the cardiovascular risk of the diabetic patient. Atorvastatin of use for diabetic patients without coronary disease, too].
MMW Fortschr Med; 2005 Aug; 147(33-34):51. PubMed ID: 16138641
[No Abstract] [Full Text] [Related]
10. Updated guidelines support even lower cholesterol levels for at-risk patients.
Levenson D
Rep Med Guidel Outcomes Res; 2004 Aug; 15(15):1, 6-7. PubMed ID: 15320342
[No Abstract] [Full Text] [Related]
11. [Atorvastatin].
Kajinami K; Takekoshi N
Nihon Rinsho; 2001 Mar; 59 Suppl 3():598-604. PubMed ID: 11347138
[No Abstract] [Full Text] [Related]
12. [Intensive LDL lowering to under 80 mg/dl: hypercholesteremia patients with stable coronary disease and diabetes profit especially significantly].
MMW Fortschr Med; 2005 Aug; 147(33-34):50-1. PubMed ID: 16138640
[No Abstract] [Full Text] [Related]
13. [For coronary disease patients is certain: the lower the LDL the better].
MMW Fortschr Med; 2006 Jun; 148(24):6. PubMed ID: 16850797
[No Abstract] [Full Text] [Related]
14. Journal Watch: evidence that Atorvastatin reduces the risk of stroke and myocardial infarction in patients with type 2 diabetes, but with no evidence of dyslipidaemia.
Gangaidzo IT
Cent Afr J Med; 2005; 51(11-12):125-6. PubMed ID: 17447346
[No Abstract] [Full Text] [Related]
15. [Considerable LDL lowering is advantageous].
MMW Fortschr Med; 2005 Sep; 147(35-36):9. PubMed ID: 16180563
[No Abstract] [Full Text] [Related]
16. [Lean years for patients].
Klose G; Anlauf M
MMW Fortschr Med; 2004 Dec; 146(51-52):16. PubMed ID: 15675237
[No Abstract] [Full Text] [Related]
17. [After TIA and stroke: a statin for secondary prevention?].
MMW Fortschr Med; 2006 Jun; 148(24):10. PubMed ID: 16850798
[No Abstract] [Full Text] [Related]
18. [How can lipid therapy be improved? Cardiologists insist on dual cholesterol inhibition].
MMW Fortschr Med; 2005 Nov; 147(45):54. PubMed ID: 16320655
[No Abstract] [Full Text] [Related]
19. [AVERT [The Atorvastatin versus Revascularization Treatment]].
Mokuno H
Nihon Rinsho; 2001 Mar; 59 Suppl 3():436-41. PubMed ID: 11347110
[No Abstract] [Full Text] [Related]
20. [CARDS confirms usefulness of LDL lowering in type 2 diabetics].
Bern VH
Praxis (Bern 1994); 2004 Oct; 93(44):1 p following 1830. PubMed ID: 15559908
[No Abstract] [Full Text] [Related]
[Next] [New Search]
